Artículos de revistas sobre el tema "HNSC CANCER TREATMENT"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "HNSC CANCER TREATMENT".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Agee, Robert, Samuel Flashner, Masataka Shimonosono, Andres Klein-Szanto y Hiroshi Nakagawa. "Abstract 3082: Leveraging 3D organoids to identify molecular changes underlying HNSC initiation and development". Cancer Research 82, n.º 12_Supplement (15 de junio de 2022): 3082. http://dx.doi.org/10.1158/1538-7445.am2022-3082.
Texto completoBurkart, Sebastian, Christopher Weusthof, Karam Khorani, Sonja Steen, Fabian Stögbauer, Kristian Unger, Julia Hess et al. "A Novel Subgroup of UCHL1-Related Cancers Is Associated with Genomic Instability and Sensitivity to DNA-Damaging Treatment". Cancers 15, n.º 6 (8 de marzo de 2023): 1655. http://dx.doi.org/10.3390/cancers15061655.
Texto completoZhao, Yixuan, Xin Huang, Zewei Zhang, Haizhou Li y Tao Zan. "The Long Noncoding Transcript HNSCAT1 Activates KRT80 and Triggers Therapeutic Efficacy in Head and Neck Squamous Cell Carcinoma". Oxidative Medicine and Cellular Longevity 2022 (4 de agosto de 2022): 1–19. http://dx.doi.org/10.1155/2022/4156966.
Texto completoTang, Shouyi, Li Zhao, Xing-Bo Wu, Zhen Wang, Lu-Yao Cai, Dan Pan, Ying Li, Yu Zhou y Yingqiang Shen. "Identification of a Novel Cuproptosis-Related Gene Signature for Prognostic Implication in Head and Neck Squamous Carcinomas". Cancers 14, n.º 16 (18 de agosto de 2022): 3986. http://dx.doi.org/10.3390/cancers14163986.
Texto completoPradhan, Sultan y Arsheed Hussain Hakeem. "Management of Head and Neck Cancer: Surgical and Nonsurgical". An International Journal of Otorhinolaryngology Clinics 2, n.º 1 (2010): 77–85. http://dx.doi.org/10.5005/jp-journals-10003-1020.
Texto completoChen, Yin-Ju, Joseph T. Chang, Guo-Rung You, Chun-Yu Huang, Kang-Hsing Fan y Ann-Joy Cheng. "Panel biomarkers associated with cancer invasion and prognostic prediction for head–neck cancer". Biomarkers in Medicine 15, n.º 11 (agosto de 2021): 861–77. http://dx.doi.org/10.2217/bmm-2021-0213.
Texto completoChuang, Yi-Hsuan, Chun-Yu Lin, Jih-Chin Lee, Chia-Hwa Lee, Chia-Lin Liu, Sing-Han Huang, Jung-Yu Lee, Wen-Sen Lai y Jinn-Moon Yang. "Identification of the HNSC88 Molecular Signature for Predicting Subtypes of Head and Neck Cancer". International Journal of Molecular Sciences 24, n.º 17 (22 de agosto de 2023): 13068. http://dx.doi.org/10.3390/ijms241713068.
Texto completoPark, Jun-Ook, Young Min Park, Woo-Jin Jeong, Yoo Seob Shin, Yong Tae Hong, Ik Joon Choi, Ji Won Kim et al. "Survival Benefits From Surgery for Stage IVa Head and Neck Squamous Cell Carcinoma: A Multi-Institutional Analysis of 1,033 Cases". Clinical and Experimental Otorhinolaryngology 14, n.º 2 (1 de mayo de 2021): 225–34. http://dx.doi.org/10.21053/ceo.2020.01732.
Texto completoXu, Chengbo, Hongfang Xu y Baimei Liu. "Head and neck squamous cell carcinoma-specific prognostic signature and drug sensitive subtypes based on programmed cell death-related genes". PeerJ 11 (21 de noviembre de 2023): e16364. http://dx.doi.org/10.7717/peerj.16364.
Texto completoHill, James H., Randall L. Plant, David M. Harris y Randal C. Paniello. "Photodynamic Therapy for Head and Neck Cancer Xenografts in Athymic Mice". Otolaryngology–Head and Neck Surgery 95, n.º 5 (diciembre de 1986): 602–6. http://dx.doi.org/10.1177/019459988609500515.
Texto completoFekete, János Tibor, Ágnes Welker y Balázs Győrffy. "miRNA Expression Signatures of Therapy Response in Squamous Cell Carcinomas". Cancers 13, n.º 1 (28 de diciembre de 2020): 63. http://dx.doi.org/10.3390/cancers13010063.
Texto completoGrau, J. J., M. Caballero, E. Verger y J. L. Blanch. "Actual proportion of patients (pts) receiving chemotherapy or cetuximab for head and neck squamous carcinoma (HNSC)". Journal of Clinical Oncology 27, n.º 15_suppl (20 de mayo de 2009): e17058-e17058. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.e17058.
Texto completoBaulch, Janet E., Munjal M. Acharya, Barrett D. Allen, Ning Ru, Nicole N. Chmielewski, Vahan Martirosian, Erich Giedzinski et al. "Cranial grafting of stem cell-derived microvesicles improves cognition and reduces neuropathology in the irradiated brain". Proceedings of the National Academy of Sciences 113, n.º 17 (4 de abril de 2016): 4836–41. http://dx.doi.org/10.1073/pnas.1521668113.
Texto completoZewde, Makda Getachew, Daniel Fulop, Alexander Tsankov y Kuan-lin Huang. "Abstract A47: Characterization of immune cell composition across cancer types in pan-cancer genomic cohorts". Cancer Immunology Research 10, n.º 12_Supplement (1 de diciembre de 2022): A47. http://dx.doi.org/10.1158/2326-6074.tumimm22-a47.
Texto completoYang, Linhui, Zhiwei Chen, Yunliang Liu, Xiaoyan Wang, Jing Li y Qing Ye. "Immunization Combined with Ferroptosis Related Genes to Construct a New Prognostic Model for Head and Neck Squamous Cell Carcinoma". Cancers 14, n.º 17 (24 de agosto de 2022): 4099. http://dx.doi.org/10.3390/cancers14174099.
Texto completoErdim, Ibrahim. "Parotidectomy in head-neck skin cancers: Our clinical experience". Praxis of Otorhinolaryngology 10, n.º 3 (27 de octubre de 2022): 101–9. http://dx.doi.org/10.5606/kbbu.2022.88262.
Texto completoKim, Nari, Mi-Hyun Kim, Junhee Pyo, Soo-Min Lee, Ji-Sung Jang, Do-Wan Lee y Kyung Won Kim. "CCR8 as a Therapeutic Novel Target: Omics-Integrated Comprehensive Analysis for Systematically Prioritizing Indications". Biomedicines 11, n.º 11 (27 de octubre de 2023): 2910. http://dx.doi.org/10.3390/biomedicines11112910.
Texto completoMadan, Sanna, Sanju Sinha, Alejandro A. Schäffer y Eytan Ruppin. "Abstract LB062: Identifying novel targets for CAR-T therapies from single cell RNA-sequencing data". Cancer Research 83, n.º 8_Supplement (14 de abril de 2023): LB062. http://dx.doi.org/10.1158/1538-7445.am2023-lb062.
Texto completoLi, Yuan, Jiagen Li, Nan Sun, Mei Luo, Chengcheng Zhou, Xuejiao Shi, Wenhui Yang, Zhiliang Lu, Zhaoli Chen y Jie He. "Identification and functional characterization of long noncoding RNA NMR as biomarker for metastasis and prognosis in esophageal squamous cell carcinoma." Journal of Clinical Oncology 35, n.º 15_suppl (20 de mayo de 2017): e15587-e15587. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.e15587.
Texto completoAcharya, Munjal M., Lori-Ann Christie, Thomas G. Hazel, Karl K. Johe y Charles L. Limoli. "Transplantation of Human Fetal-Derived Neural Stem Cells Improves Cognitive Function following Cranial Irradiation". Cell Transplantation 23, n.º 10 (octubre de 2014): 1255–66. http://dx.doi.org/10.3727/096368913x670200.
Texto completoLee, Suyeon, Heewon Jung, Jiwoo Park y Jaegyoon Ahn. "Accurate Prediction of Cancer Prognosis by Exploiting Patient-Specific Cancer Driver Genes". International Journal of Molecular Sciences 24, n.º 7 (29 de marzo de 2023): 6445. http://dx.doi.org/10.3390/ijms24076445.
Texto completoKholod, Olha, William Basket, Danlu Liu, Jonathan Mitchem, Jussuf Kaifi, Laura Dooley y Chi-Ren Shyu. "Identification of Immuno-Targeted Combination Therapies Using Explanatory Subgroup Discovery for Cancer Patients with EGFR Wild-Type Gene". Cancers 14, n.º 19 (29 de septiembre de 2022): 4759. http://dx.doi.org/10.3390/cancers14194759.
Texto completoLv, Ran, Fang Lv, Pei Zhihua, Jianing Yu, Xiuyu Zhao, Yiqian Liu, Yaxi Zhang, Geng Chen, Weizhi Chen y Ji He. "Noninvasive detection of chromosomal instability in plasma circulating cell-free DNA for early pan-cancer diagnosis using low-pass whole-genome sequencing." Journal of Clinical Oncology 39, n.º 15_suppl (20 de mayo de 2021): e22509-e22509. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.e22509.
Texto completoKoenigs, Maria B., Armida Lefranc-Torres, Juliana Bonilla-Velez, Krupal B. Patel, D. Neil Hayes, Krzysztof Glomski, Paul M. Busse et al. "Association of Estrogen Receptor Alpha Expression With Survival in Oropharyngeal Cancer Following Chemoradiation Therapy". JNCI: Journal of the National Cancer Institute 111, n.º 9 (31 de enero de 2019): 933–42. http://dx.doi.org/10.1093/jnci/djy224.
Texto completoLiu, Jinhui, Yuanyuan Wang, Jian Yin, Yan Yang, Rui Geng, Zihang Zhong, Senmiao Ni et al. "Pan-Cancer Analysis Revealed SRSF9 as a New Biomarker for Prognosis and Immunotherapy". Journal of Oncology 2022 (12 de enero de 2022): 1–21. http://dx.doi.org/10.1155/2022/3477148.
Texto completoWu, Sheng, Xiangkang Lv, Yilin Li, Xinyi Gao, Zhiqi Ma, Xiao Fu y Yong Li. "Integrated Machine Learning and Single-Sample Gene Set Enrichment Analysis Identifies a TGF-Beta Signaling Pathway Derived Score in Headneck Squamous Cell Carcinoma". Journal of Oncology 2022 (1 de septiembre de 2022): 1–12. http://dx.doi.org/10.1155/2022/3140263.
Texto completoMahmoud, Yamil Damian, Florencia Veigas, Joaquin Merlo, Monica Balzarini, Dario Rocha, Gabriel Adrian Rabinovich, Elmer Fernandez y Maria Romina Romina Girotti. "Bioinformatic profiling of tumor immunity from patient biopsies to predict survival and response to immunotherapy." Journal of Clinical Oncology 38, n.º 15_suppl (20 de mayo de 2020): e15198-e15198. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.e15198.
Texto completoCirillo, Nicola, Carmen Wu y Stephen S. Prime. "Heterogeneity of Cancer Stem Cells in Tumorigenesis, Metastasis, and Resistance to Antineoplastic Treatment of Head and Neck Tumours". Cells 10, n.º 11 (8 de noviembre de 2021): 3068. http://dx.doi.org/10.3390/cells10113068.
Texto completoPrince, Mark E. P. y Laurie E. Ailles. "Cancer Stem Cells in Head and Neck Squamous Cell Cancer". Journal of Clinical Oncology 26, n.º 17 (10 de junio de 2008): 2871–75. http://dx.doi.org/10.1200/jco.2007.15.1613.
Texto completoAnurag, Meenakshi, Eric Jaehnig, Jonathan Lei, Beom-Jun Kim, Anh Minh Tran Huynh, Yongchao Dou, Tanmayi Vashist et al. "Abstract 1010: LIG1 deletion predicts chemotherapy resistance, chromosomal instability, and poor prognosis in triple negative breast cancer". Cancer Research 82, n.º 12_Supplement (15 de junio de 2022): 1010. http://dx.doi.org/10.1158/1538-7445.am2022-1010.
Texto completoSchmidt, Henri, Arutha Kulasinghe, Richard Allcock, Lit Tan, Elisa Mokany, Liz Kenny y Chamindie Punyadeera. "A Pilot Study to Non-Invasively Track PIK3CA Mutation in Head and Neck Cancer". Diagnostics 8, n.º 4 (29 de noviembre de 2018): 79. http://dx.doi.org/10.3390/diagnostics8040079.
Texto completoShah, Amit, Shilpa Patel, Jigna Pathak, Niharika Swain y Shwetha Kumar. "The Evolving Concepts of Cancer Stem Cells in Head and Neck Squamous Cell Carcinoma". Scientific World Journal 2014 (2014): 1–8. http://dx.doi.org/10.1155/2014/842491.
Texto completoHidy, Samantha y David Weaver. "230 Single cell PIK3 gene expression patterns support duvelisib (PI3K-delta, gamma inhibitor) treatment of melanoma and other tumors after checkpoint inhibitor therapy". Journal for ImmunoTherapy of Cancer 8, Suppl 3 (noviembre de 2020): A248. http://dx.doi.org/10.1136/jitc-2020-sitc2020.0230.
Texto completoJavaid, Sehrish, Antje Schaefer, Craig M. Goodwin, Victoria V. Nguyen, Frances L. Massey, Mariaelena Pierobon, Da'Jhnae Gambrell-Sanders et al. "Concurrent Inhibition of ERK and Farnesyltransferase Suppresses the Growth of HRAS Mutant Head and Neck Squamous Cell Carcinoma". Molecular Cancer Therapeutics 21, n.º 5 (28 de febrero de 2022): 762–74. http://dx.doi.org/10.1158/1535-7163.mct-21-0142.
Texto completoSarnella, Annachiara, Ylenia Ferrara, Luigi Auletta, Sandra Albanese, Vincenzo Alterio, Jean-Yves Winum, Claudiu T. Supuran, Laura Cerchia, Giuseppina De Simone y Antonella Zannetti. "Abstract 1040: Blocking hypoxia-induced carbonic anhydrases 9 enhances sensibility to cisplatin of head and neck squamous carcinoma". Cancer Research 82, n.º 12_Supplement (15 de junio de 2022): 1040. http://dx.doi.org/10.1158/1538-7445.am2022-1040.
Texto completoPorcheri, Cristina y Thimios A. Mitsiadis. "New Scenarios in Pharmacological Treatments of Head and Neck Squamous Cell Carcinomas". Cancers 13, n.º 21 (3 de noviembre de 2021): 5515. http://dx.doi.org/10.3390/cancers13215515.
Texto completoCruz-Gregorio, Alfredo, Imelda Martínez-Ramírez, José Pedraza-Chaverri y Marcela Lizano. "Reprogramming of Energy Metabolism in Response to Radiotherapy in Head and Neck Squamous Cell Carcinoma". Cancers 11, n.º 2 (5 de febrero de 2019): 182. http://dx.doi.org/10.3390/cancers11020182.
Texto completoKrishnatry, Rahul, Tejpal Gupta, Vedang Murthy, Sudhir Vasudevan Nair, Deepa Nair, Pankaj Chaturvedi, A. K. Dcruz et al. "Distant metastasis in head and neck cancer: Baseline factors." Journal of Clinical Oncology 30, n.º 15_suppl (20 de mayo de 2012): e16021-e16021. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.e16021.
Texto completoMiari, Reem, Naiel Azzam, Rinat Bar-Shalom y Fuad Fares. "5-aza-2’-deoxycytidine induces apoptosis and inhibits tumour growth in vivo of FaDu cells, a specific HPVnegative HNSCC cell line". PLOS ONE 16, n.º 9 (17 de septiembre de 2021): e0253756. http://dx.doi.org/10.1371/journal.pone.0253756.
Texto completoPillai, Sangeeth, Jan C. Kwan, Fares Yaziji, Hanwen Yu y Simon D. Tran. "Mapping the Potential of Microfluidics in Early Diagnosis and Personalized Treatment of Head and Neck Cancers". Cancers 15, n.º 15 (31 de julio de 2023): 3894. http://dx.doi.org/10.3390/cancers15153894.
Texto completoSingh, Khushwant y Pramod kumar Gautam. "Emulating the Role of Neutrophils in Head and Neck Cancer Microenvironment: Prognostic Role and Therapeutic Strategies". Journal of Cancer Immunology 5, n.º 2 (28 de agosto de 2023): 61–73. http://dx.doi.org/10.33696/cancerimmunol.5.076.
Texto completoXia, Yu, Xiuqin Li y Wei Sun. "Applications of Recombinant Adenovirus-p53 Gene Therapy for Cancers in the Clinic in China". Current Gene Therapy 20, n.º 2 (18 de septiembre de 2020): 127–41. http://dx.doi.org/10.2174/1566523220999200731003206.
Texto completoShrestha, Gambhir, Bhola Siwakoti, Rashmi Mulmi y Dejkumar Gautam. "Trend of Head and Neck Cancers in a National Tertiary Cancer Hospital of Nepal from 2012 to 2017". South Asian Journal of Cancer 10, n.º 04 (diciembre de 2021): 236–40. http://dx.doi.org/10.1055/s-0041-1731131.
Texto completoKong, Lingyi y Andrew C. Birkeland. "Liquid Biopsies in Head and Neck Cancer: Current State and Future Challenges". Cancers 13, n.º 8 (14 de abril de 2021): 1874. http://dx.doi.org/10.3390/cancers13081874.
Texto completoLiu, Xiqiang, Zugen Chen, Jinsheng Yu, James Xia y Xiaofeng Zhou. "MicroRNA Profiling and Head and Neck Cancer". Comparative and Functional Genomics 2009 (2009): 1–11. http://dx.doi.org/10.1155/2009/837514.
Texto completoBejenaru, Paula Luiza, Bogdan Popescu, Alina Lavinia Antoaneta Oancea, Catrinel Beatrice Simion-Antonie, Gloria Simona Berteșteanu, Mihnea Condeescu-Cojocarița, Anca Ionela Cîrstea et al. "Quality-of-Life Assessment after Head and Neck Oncological Surgery for Advanced-Stage Tumours". Journal of Clinical Medicine 11, n.º 16 (19 de agosto de 2022): 4875. http://dx.doi.org/10.3390/jcm11164875.
Texto completoMeliante, Piero Giuseppe, Carla Petrella, Marco Fiore, Antonio Minni y Christian Barbato. "Antioxidant Use after Diagnosis of Head and Neck Squamous Cell Carcinoma (HNSCC): A Systematic Review of Application during Radiotherapy and in Second Primary Cancer Prevention". Antioxidants 12, n.º 9 (12 de septiembre de 2023): 1753. http://dx.doi.org/10.3390/antiox12091753.
Texto completoRühle, Alexander, Anca-Ligia Grosu y Nils H. Nicolay. "De-Escalation Strategies of (Chemo)Radiation for Head-and-Neck Squamous Cell Cancers—HPV and Beyond". Cancers 13, n.º 9 (4 de mayo de 2021): 2204. http://dx.doi.org/10.3390/cancers13092204.
Texto completoKuo, Selena Z., Christine O. Honda, Wei Tse Li, Thomas K. Honda, Elizabeth Kim, Xabier Altuna, Eric Abhold, Jessica Wang-Rodriguez y Weg M. Ongkeko. "Metformin Results in Diametrically Opposed Effects by Targeting Non-Stem Cancer Cells but Protecting Cancer Stem Cells in Head and Neck Squamous Cell Carcinoma". International Journal of Molecular Sciences 20, n.º 1 (7 de enero de 2019): 193. http://dx.doi.org/10.3390/ijms20010193.
Texto completoAllevato, Michael, Yumi Yokoyama, Robert Wild y J. Silvio Gutkind. "Abstract 3027: Elucidating the role of glutamine metabolism in head & neck squamous cell carcinoma". Cancer Research 82, n.º 12_Supplement (15 de junio de 2022): 3027. http://dx.doi.org/10.1158/1538-7445.am2022-3027.
Texto completo